<DOC>
	<DOCNO>NCT00973869</DOCNO>
	<brief_summary>RATIONALE : Chemoprevention use certain drug keep cancer forming . The use curcumin may prevent treat colorectal cancer . PURPOSE : This phase I trial study side effect curcumin prevent colorectal cancer patient undergoing colorectal endoscopy colorectal surgery .</brief_summary>
	<brief_title>Curcumin Preventing Colorectal Cancer Patients Undergoing Colorectal Endoscopy Colorectal Surgery</brief_title>
	<detailed_description>OBJECTIVES : Primary - To determine level curcumin metabolite normal colorectal tissue patient undergoing colorectal endoscopy colorectal cancer surgery follow 14-day course curcumin . Secondary - To assess practicality , acceptability , safety administer 5 capsule curcumin daily 14 day . - To check presence curcumin metabolites peripheral blood urine . OUTLINE : Patients receive oral curcumin daily 14-28 day . Patients undergo colorectal endoscopy resection . Normal colorectal tissue sample collect via biopsy curcumin assay last dose curcumin . Patients also undergo blood urine sample collection baseline last dose curcumin pharmacokinetic analysis high performance liquid chromatography . After completion study treatment , patient follow 14 day .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Meets 1 follow criterion : Has positive fecal occult blood test find pilot colorectal cancer screen program Awaiting diagnostic surveillance colonoscopy Diagnosis colorectal cancer PATIENT CHARACTERISTICS : Able return followup test Fertile patient must use effective contraception No discrete gastric duodenal ulcer &gt; 5 mm past year Patients history Helicobacter pylorirelated peptic ulcer disease eligible successfully complete antibiotic treatment Helicobacter pylori No significant medical psychiatric problem , include significant renal , hepatic , hematological dysfunction , would make patient poor candidate study PRIOR CONCURRENT THERAPY : More 3 month since prior investigational agent No prior pelvic radiotherapy No concurrent investigational agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>colon cancer</keyword>
	<keyword>rectal cancer</keyword>
</DOC>